# Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

> **NCT05027048** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 120 (actual)

## Conditions studied

- Uterine Atony
- Uterine Atony With Hemorrhage
- Postpartum Hemorrhage
- Cesarean Section Complications

## Interventions

- **DRUG:** Calcium chloride
- **DRUG:** Saline placebo

## Key facts

- **NCT ID:** NCT05027048
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-04
- **Primary completion:** 2023-03-29
- **Final completion:** 2023-04-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027048, "Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05027048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*